GlaxoSmithKline vaccine agreement

GlaxoSmithKline Plc has agreed to market Bavarian Nordic A/S’s Imvamune vaccine for smallpox.
GlaxoSmithKline vaccine agreement

Bavarian will be responsible for development and production under a current contract with the US National Institutes of Health.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited